Midaia

Revolutionizing Clinical Research in Rheumatology. Midaia is a specialized "CRO 2.0" that combines medical expertise with digital innovation. We solve the biggest challenges in modern clinical research: slow recruitment and the lack of high-quality data from the patient’s daily life. What we do: We operate the Midaia Rheuma App, a CE-certified digital platform that supports patients with inflammatory rheumatic diseases while capturing structured, longitudinal Real-World Data (RWD). How we support Pharma & Life-Science Partners: Real-World Evidence: Gain insights into treatment adherence, symptom patterns, and quality of life between clinic visits. Faster Time-to-Market: Leverage our existing patient community for rapid study recruitment. End-to-End Digital Studies: From eConsent to ePROs – we provide a GCP-compliant digital infrastructure that integrates directly into your EDC systems. Medical Excellence: Our deep focus on rheumatology ensures that we speak the language of both investigators and sponsors. Driven by the vision of a patient-centric research landscape, Midaia is proud to be supported by the EULAR and trusted by industry leaders like Pfizer. Visit us at: Part of the BLS Group | Heidelberg, Germany